Redeye comments on SciBase’s rights issue outcome. The issue was subscribed to 73.4%, with the remaining 26.6% covered by the underwriting commitment. We view the outcome as solid and leave our valuation unchanged, as full subscription was already incorporated into our model.
LÄS MER
